Synthesis and antimetabolic properties of 4,5-substituted pyrimidine 2'-deoxynucleosides and their 5'-monophosphates. 1987

T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warszawa.

Reaction of the reagent of Lawesson, 2,4-bis(p-methoxyphenyl)-1,3,4-dithiadiphosphatane-2,4-disulfide, with blocked uracil nucleosides in dioxane leads to quantitative thionation at C(4). With the bases, thionation occurs at C(4) and, with two equivalents of the reagent, at C(2) and C(4). Enzymatic phosphorylation of 4-thio-FdUrd gave the 5'-monophosphate, which was further converted with NH2OH to N4-hydroxy-FdCMP. Both nucleotides were examined as potential inhibitors of thymidylate synthase, and 4-thio-FdUrd for cytotoxic activities vs monkey and human leukemic cell lines.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D011742 Pyrimidine Nucleotides Pyrimidines with a RIBOSE and phosphate attached that can polymerize to form DNA and RNA. Nucleotides, Pyrimidine
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013940 Thymidylate Synthase An enzyme of the transferase class that catalyzes the reaction 5,10-methylenetetrahydrofolate and dUMP to dihydrofolate and dTMP in the synthesis of thymidine triphosphate. (From Dorland, 27th ed) EC 2.1.1.45. Thymidylate Synthetase,Synthase, Thymidylate,Synthetase, Thymidylate

Related Publications

T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
January 1993, Nucleic acids symposium series,
T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
March 2021, Chemical science,
T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
October 2020, Chemical science,
T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
January 1971, The Journal of organic chemistry,
T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
August 2003, The Journal of organic chemistry,
T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
January 1982, Molecular pharmacology,
T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
August 1995, Bioorganicheskaia khimiia,
T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
January 1965, Chemical & pharmaceutical bulletin,
T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
May 1975, Biochemical pharmacology,
T Kulikowski, and M Bretner, and J M Dzik, and Z Zieliński, and J Cieśla, and W Rode, and J A Vilpo, and D Shugar
July 2020, Organic & biomolecular chemistry,
Copied contents to your clipboard!